- $10.43bn
- $28.29bn
- $3.41bn
- 72
- 39
- 79
- 68
Annual income statement for BXP, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,766 | 2,889 | 3,109 | 3,274 | 3,408 |
Cost of Revenue | |||||
Gross Profit | 1,724 | 1,842 | 1,958 | 2,040 | 2,069 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,860 | 1,966 | 2,050 | 2,239 | 2,401 |
Operating Profit | 905 | 923 | 1,059 | 1,034 | 1,007 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,019 | 632 | 1,021 | 291 | 84.2 |
Net Income After Taxes | 1,019 | 632 | 1,021 | 291 | 84.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 873 | 505 | 849 | 190 | 14.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 862 | 496 | 848 | 190 | 14.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.57 | 2.7 | 2.57 | 1.23 | 0.183 |
Dividends per Share |